Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02589171 · ClinicalTrials.gov registry record · NA
The neoClose Abdominal Closure vs Carter-Thomason Trial
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT02589171 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 70 participants.
The verdict
NCT02589171, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the neoClose abdominal closure to the standard Carter-Thomason closure in a bariatric surgery gastric bypass population.
Interventions
- DEVICE Neo Close Abdominal Closure
- DEVICE Carter Thomason Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-02-12 |
| Est. Completion | 2018-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02589171
The ClinicalTrials.gov registry entry for NCT02589171 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neo Close Abdominal Closure is the first listed.
NCT02589171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02589171 about?
NCT02589171 is a clinical study titled "The neoClose Abdominal Closure vs Carter-Thomason Trial". The purpose of this study is to compare the neoClose abdominal closure to the standard Carter-Thomason closure in a bariatric surgery gastric bypass population.
What is the current status of trial NCT02589171?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2016-02-12. Estimated completion is 2018-04-25.
What interventions are being tested in trial NCT02589171?
The interventions under investigation include: Neo Close Abdominal Closure (DEVICE), Carter Thomason Device (DEVICE).
Who is sponsoring clinical trial NCT02589171?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.